<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 09:14:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Kari Hale</title>
		<link>http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/comment-page-1/#comment-79699</link>
		<dc:creator>Kari Hale</dc:creator>
		<pubDate>Fri, 04 Sep 2009 17:41:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38805#comment-79699</guid>
		<description>Thank you for acknowledging this wonderful biotech as I am one that benefited from its existence.  TGC was a mentoring ground that provided many just out of college a place to understand the industry but still base decisions and projects on research not just the bottom line.  The management led by Stewart and Barrie surrounded us with enthusiasm and support if you were cleaning the glassware or leading pre-clinical trials your input was essential.  A disease might not have been cured(YET-technology lives on) yet TGC pushed the science bar and produced leading edge biotech-ers. THANK YOU TGC &amp; I miss happy hour intercom calls!</description>
		<content:encoded><![CDATA[<p>Thank you for acknowledging this wonderful biotech as I am one that benefited from its existence.  TGC was a mentoring ground that provided many just out of college a place to understand the industry but still base decisions and projects on research not just the bottom line.  The management led by Stewart and Barrie surrounded us with enthusiasm and support if you were cleaning the glassware or leading pre-clinical trials your input was essential.  A disease might not have been cured(YET-technology lives on) yet TGC pushed the science bar and produced leading edge biotech-ers. THANK YOU TGC &amp; I miss happy hour intercom calls!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Justine Dell'Aringa</title>
		<link>http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/comment-page-1/#comment-79461</link>
		<dc:creator>Justine Dell'Aringa</dc:creator>
		<pubDate>Thu, 03 Sep 2009 19:01:08 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38805#comment-79461</guid>
		<description>What a pleasant surprise it is to come across this article, indeed TGC was an excellent training ground and inspirational place to work.  I always felt fortunate that I was hired at TGC right out of collage.  I was trained by top notch scientists and surround by innovation and wonderful people excited about the work they were doing, what a great first introduction to the biotech industry!  …and not doubt, Stewart Parker is a wonderful leader and an excellent example of a talented and successful woman in science.  It’s nice to think of all that hard work infiltrating and energizing the local biotech industry.  I most definitely have applied the skills I acquired while working at TGC at other companies and still am today.  Thanks for pointing out the positive, and thanks to everyone who made TGC such a great place to work.</description>
		<content:encoded><![CDATA[<p>What a pleasant surprise it is to come across this article, indeed TGC was an excellent training ground and inspirational place to work.  I always felt fortunate that I was hired at TGC right out of collage.  I was trained by top notch scientists and surround by innovation and wonderful people excited about the work they were doing, what a great first introduction to the biotech industry!  …and not doubt, Stewart Parker is a wonderful leader and an excellent example of a talented and successful woman in science.  It’s nice to think of all that hard work infiltrating and energizing the local biotech industry.  I most definitely have applied the skills I acquired while working at TGC at other companies and still am today.  Thanks for pointing out the positive, and thanks to everyone who made TGC such a great place to work.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Luke Timmerman</title>
		<link>http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/comment-page-1/#comment-77495</link>
		<dc:creator>Luke Timmerman</dc:creator>
		<pubDate>Wed, 26 Aug 2009 00:20:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38805#comment-77495</guid>
		<description>Tony---thanks very much for this very informative comment. I actually thought about using LinkedIn for this story, but hesitated because I&#039;ve noticed some people letting their profiles get out of date. If anybody here on the list has a new title or employer, you can update it here in the comment stream. 

Luke</description>
		<content:encoded><![CDATA[<p>Tony—thanks very much for this very informative comment. I actually thought about using LinkedIn for this story, but hesitated because I’ve noticed some people letting their profiles get out of date. If anybody here on the list has a new title or employer, you can update it here in the comment stream. </p>
<p>Luke</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tony</title>
		<link>http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/comment-page-1/#comment-77484</link>
		<dc:creator>Tony</dc:creator>
		<pubDate>Tue, 25 Aug 2009 23:40:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38805#comment-77484</guid>
		<description>Luke,

Thanks for touching upon this undeniable and rarely mentioned aspect of the Targeted Genetics story. Throughout its 17 year roller coaster ride TGC has not only been a major career stepping stone for many, but also a source of enduring friendships (as well as a number number of marriages;). Although the company&#039;s contribution to the bruised local biotech economy is sadly waning its DNA is very much woven in the current landscape as evidenced by the following Linked0n list of former TGC employees that are still active and contributing in the local scene:

Tara Allen, Clinical Research Associate at Dendreon

Deborah Garrard, Senior Project Manager at Seattle Genetics

Edward Kelly, Research Assistant Professor at University of Washington

Daryn Debelak, Seattle Account Manager Invitrogen Life Tech 

Perry Wilkins, Seattle Account Manager Invirtogen Life Tech 
Tsering Sangmo, Sr. Lab Tech, Seattle

Peter Olagunju, Compliance Manager, ZymoGenetics Inc.

Ian Aranha, Associate Scientist - Bayer 
HealthCare Pharmaceuticals - Seattle

Alison Grady, QC Supervisor/Project Manager

Simon Grainger, Seattle Account Manager at VWR International

Devon DeHaas, Seattle Account Manager at VWR International

Kari Hale, Associate Scientist at Amgen

Pierrot Harvie, Research Scientist at MDRNA
 
Haim Burstein, Scientist

Aimee Roy, QA Supervisor at Dendreon Corporation

Ave-teel Connie, Lab Support, Manager at ICOS Corporation

Damon Jacobson, Clinical Research Associate in Hematology/Oncology

Tony Stepan   - Seattle Applications Specialist at Promega

Justine Dell&#039;Aringa- Associate Scientist at Amgen

Eric Eith, ZymoGenetics

Christine Moore,QA Associate - Seattle Cancer Care Alliance

Paul Engelbrecht,Quality Control Supervisor Dendreon

Keith Munson,Senior CMC Project Manager at CMC ICOS Biologics

Charles Wallsmith, Biotech IT Consultant

Gina Nichols, Staff Scientist 

Leah Zielinski Yount , QA Associate at Seattle Biomedical Research Institute

Rema Assaf, Senior Project Manager at Seattle Genetics

Brad Miller - QC Supervisor at Bio-Rad Laboratories

Paul Hara, Senior Director, Program Management at MDS Pharma Services

Ben Dutzar , Research Scientist at Alder Biopharmaceuticals

Eric Keeler , Sales and Business Development
Alison Grady, QC Supervisor/Project Manager

Holly Craven, QC Analyst ZymoGenetics

Tina Quinton, Patent Attorney at Christensen O&#039;Connor Johnson Kindness

Lara Stepan, Scientist Amgen

Lawrence Evans, Scientist Amgen
Lisa 
Linda Wilson, Scientist Amgen

Eden Zasloff, Clinical Research Associate

Lori Jones, Cellular Immunologist Seattle Cancer Care Alliance

Teresa Johnston Manager Quality Control at CMC ICOS Corporation
Chuck Smith, Sr. Director of Quality at Seattle Genetics

Kevin Anderson, Principal Scientist at Seattle Genetics

Susan Bell, Research Associate at MDRNA Inc

Andrew Feldhaus, Principal Scientist at ZymoGenetics

Todd Allen, Technical Operations at ZymoGenetics

Emily Bradeen-Duncan, Manufacturing QA Associate II at Seattle Genetics

Jason Orthel, Pharmacist Seattle</description>
		<content:encoded><![CDATA[<p>Luke,</p>
<p>Thanks for touching upon this undeniable and rarely mentioned aspect of the Targeted Genetics story. Throughout its 17 year roller coaster ride TGC has not only been a major career stepping stone for many, but also a source of enduring friendships (as well as a number number of marriages;). Although the company’s contribution to the bruised local biotech economy is sadly waning its DNA is very much woven in the current landscape as evidenced by the following Linked0n list of former TGC employees that are still active and contributing in the local scene:</p>
<p>Tara Allen, Clinical Research Associate at Dendreon</p>
<p>Deborah Garrard, Senior Project Manager at Seattle Genetics</p>
<p>Edward Kelly, Research Assistant Professor at University of Washington</p>
<p>Daryn Debelak, Seattle Account Manager Invitrogen Life Tech </p>
<p>Perry Wilkins, Seattle Account Manager Invirtogen Life Tech<br />
Tsering Sangmo, Sr. Lab Tech, Seattle</p>
<p>Peter Olagunju, Compliance Manager, ZymoGenetics Inc.</p>
<p>Ian Aranha, Associate Scientist – Bayer<br />
HealthCare Pharmaceuticals – Seattle</p>
<p>Alison Grady, QC Supervisor/Project Manager</p>
<p>Simon Grainger, Seattle Account Manager at VWR International</p>
<p>Devon DeHaas, Seattle Account Manager at VWR International</p>
<p>Kari Hale, Associate Scientist at Amgen</p>
<p>Pierrot Harvie, Research Scientist at MDRNA</p>
<p>Haim Burstein, Scientist</p>
<p>Aimee Roy, QA Supervisor at Dendreon Corporation</p>
<p>Ave-teel Connie, Lab Support, Manager at ICOS Corporation</p>
<p>Damon Jacobson, Clinical Research Associate in Hematology/Oncology</p>
<p>Tony Stepan   – Seattle Applications Specialist at Promega</p>
<p>Justine Dell’Aringa- Associate Scientist at Amgen</p>
<p>Eric Eith, ZymoGenetics</p>
<p>Christine Moore,QA Associate – Seattle Cancer Care Alliance</p>
<p>Paul Engelbrecht,Quality Control Supervisor Dendreon</p>
<p>Keith Munson,Senior CMC Project Manager at CMC ICOS Biologics</p>
<p>Charles Wallsmith, Biotech IT Consultant</p>
<p>Gina Nichols, Staff Scientist </p>
<p>Leah Zielinski Yount , QA Associate at Seattle Biomedical Research Institute</p>
<p>Rema Assaf, Senior Project Manager at Seattle Genetics</p>
<p>Brad Miller – QC Supervisor at Bio-Rad Laboratories</p>
<p>Paul Hara, Senior Director, Program Management at MDS Pharma Services</p>
<p>Ben Dutzar , Research Scientist at Alder Biopharmaceuticals</p>
<p>Eric Keeler , Sales and Business Development<br />
Alison Grady, QC Supervisor/Project Manager</p>
<p>Holly Craven, QC Analyst ZymoGenetics</p>
<p>Tina Quinton, Patent Attorney at Christensen O’Connor Johnson Kindness</p>
<p>Lara Stepan, Scientist Amgen</p>
<p>Lawrence Evans, Scientist Amgen<br />
Lisa<br />
Linda Wilson, Scientist Amgen</p>
<p>Eden Zasloff, Clinical Research Associate</p>
<p>Lori Jones, Cellular Immunologist Seattle Cancer Care Alliance</p>
<p>Teresa Johnston Manager Quality Control at CMC ICOS Corporation<br />
Chuck Smith, Sr. Director of Quality at Seattle Genetics</p>
<p>Kevin Anderson, Principal Scientist at Seattle Genetics</p>
<p>Susan Bell, Research Associate at MDRNA Inc</p>
<p>Andrew Feldhaus, Principal Scientist at ZymoGenetics</p>
<p>Todd Allen, Technical Operations at ZymoGenetics</p>
<p>Emily Bradeen-Duncan, Manufacturing QA Associate II at Seattle Genetics</p>
<p>Jason Orthel, Pharmacist Seattle</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Targeted Genetics Family Spreads Across Seattle Biotech, as &#8230; &#124; Seattle News on Twitter</title>
		<link>http://www.xconomy.com/seattle/2009/08/25/targeted-genetics-family-spreads-across-seattle-biotech-as-company-struggles-to-live/comment-page-1/#comment-77274</link>
		<dc:creator>Targeted Genetics Family Spreads Across Seattle Biotech, as &#8230; &#124; Seattle News on Twitter</dc:creator>
		<pubDate>Tue, 25 Aug 2009 08:34:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38805#comment-77274</guid>
		<description>[...] Link: Targeted Genetics Family Spreads Across Seattle Biotech, as &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] Link: Targeted Genetics Family Spreads Across Seattle Biotech, as … [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

